Table 1.
Characteristics | Total n (%) or mean (SD) n = 91 | Current prescribers n (%) or mean (SD) n = 60 | Nonprescribers n (%) or mean (SD) n = 31 | OR (95% CI) | p value |
---|---|---|---|---|---|
Age | 52 (12.8) N = 83 |
53.9 (13.3) N = 55 |
48.1 (11.1) N = 28 |
1.04 (0.99–1.08) | 0.055 |
Gender | |||||
Male | 64 (70.3) | 42 (70.0) | 22 (71.0) | Reference | |
Female | 27 (29.7) | 18 (30.0) | 9 (29.0) | 1.05 (0.40–2.71) | 0.924 |
Race/ethnicity | |||||
White | 66 (70.3) | 48 (80.0) | 18 (58.1) | Reference | |
Non-white | 25 (27.5) | 12 (20.0) | 13 (41.9) | 0.35 (0.13–0.90) | 0.029 |
Geographic location | |||||
New York City | 52 (57.1) | 33 (55.0) | 19 (61.3) | Reference | |
Outside New York City | 39 (42.9) | 27 (44.5) | 12 (38.7) | 1.30 (0.54–3.14) | 0.566 |
Years in practice | 19 (13) N = 85 |
21.6 (13.7) N = 55 |
14.5 (10.3) N = 30 |
1.05 (1.01–1.10) | 0.022 |
Primary practice specialty | |||||
Psychiatry | 44 (48.4) | 25 (41.7) | 18 (58.1) | Reference | |
Medicine | 35 (38.5) | 28 (46.7) | 8 (25.8) | 2.52 (0.93–6.80) | 0.068 |
Other | 12 (13.2) | 7 (11.7) | 5 (16.1) | 1.01 (0.28–3.69) | 0.990 |
Addiction specialty | |||||
Addiction specialist | 17 (18.7) | 15 (25.0) | 2 (6.5) | Reference | |
Nonaddiction specialist | 74 (81.3) | 45 (75.0) | 29 (93.5) | 0.21 (0.04–0.97) | 0.046 |
Primary practice type | |||||
Solo practice | 30 (33.0) | 25 (41.7) | 5 (16.1) | Reference | |
Group practice | 61 (67.0) | 35 (58.3) | 26 (83.9) | 0.27 (0.09–0.80) | 0.018 |
Academic affiliation | |||||
Yes | 51 (56.7) | 29 (48.3) | 22 (73.3) | Reference | |
No | 39 (43.3) N = 90 |
31 (51.7) N = 60 |
8 (26.7) N = 30 |
2.94 (1.13–7.64) | 0.027 |
Buprenorphine effectiveness | |||||
Heavy/moderate | 82 (90.1) | 55 (93.2) | 27 (93.1) | Reference | |
Limited/none/DK | 6 (6.6) N = 88 |
4 (6.8) N = 59 |
2 (6.9) N = 29 |
0.98 (0.17–5.70) | 0.984 |
How many other buprenorphine providers do you know? | 7.03 (8.5) N = 79 |
8.60 (10.0) N = 52 |
4.0 (2.8) N = 27 |
1.19 (1.03–1.38) | 0.020 |
DK: do not know.